Because marijuana is a Schedule I drug under the Controlled Substances Act, the therapeutic benefits of cannabis are no longer mentioned in the formal education of health care professionals. Doctors who do learn of the drug's therapeutic value are often intimidated by its illegal status. Thus millions of patients afflicted with such illnesses as glaucoma, AIDS, cancer, multiple sclerosis, spinal cord injuries, seizure disorders and chronic pain are denied access to information about the drug's benefits and, in many cases, suffer needlessly. Straightforward and nonpoliticized information on the…mehr
Because marijuana is a Schedule I drug under the Controlled Substances Act, the therapeutic benefits of cannabis are no longer mentioned in the formal education of health care professionals. Doctors who do learn of the drug's therapeutic value are often intimidated by its illegal status. Thus millions of patients afflicted with such illnesses as glaucoma, AIDS, cancer, multiple sclerosis, spinal cord injuries, seizure disorders and chronic pain are denied access to information about the drug's benefits and, in many cases, suffer needlessly. Straightforward and nonpoliticized information on the therapeutic uses of cannabis is provided here by medical, legal and scientific professionals. Legal issues, a worldwide history of therapeutic cannabis and a discussion of its pharmacology are covered. Specific medical uses are then examined, including its application for sufferers of cancer, AIDS, glaucoma, and seizure disorders, and its potential use in psychiatry. Dosages and administration of cannabis are explored, along with considerations on the use of the drug during pregnancy and the risks of addiction and dependency.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Mary Lynn Mathre, R.N., M.S.N., is an addictions specialist and is the Executive Director of the Pantops Clinic in Charlottesville, Virginia.
Inhaltsangabe
Table of Contents ACKNOWLEDGMENTS INTRODUCTION (Mary Lynn Mathre) Part I. Legal Dilemmas of Cannabis Prohibition 1. People Behind the Pain (Norman Elliott Kent) 2. Legal Issues Related to the Medical Use of Marijuana (Kevin B. Zeese) Part II. Medicinal Characteristics of Cannabis 3. History of Therapeutic Cannabis (Michael Aldrich) 4. Pharmacology and Toxicity of Cannabis (Denis J. Petro) Part III. Indications for Therapeutic Use of Cannabis 5. As an Antiemetic and Appetite Stimulant for Cancer Patients (Daniel A. Dansak) 6. AIDS and the Wasting Syndrome (Walter Krampf) 7. Glaucoma: A Patient's View (Robert C. Randall) 8. The Use of Certain Cannabis Derivatives (Canasol) in Glaucoma (Manley West) 9. Spasticity and Chronic Pain (Denis Petro) 10. Seizure Disorders (Denis Petro) 11. Use of Cannabis or THC in Psychiatry (Milton Earl Burglass) 12. Cannabidiol as an Anxiolytic and Antipsychotic (Antonio W. Zuardi and Francisco S. Guimaraes) 13. Dosage and Administration of Cannabis (Madelyn Z. Brazis and Mary Lynn Mathre) Part IV. Special Considerations 14. Cannabis and Pregnancy (Melanie C. Dreher) 15. Risk of Dependence and Addiction (Mary Lynn Mathre) 16. Nutritional Value of Hemp Seed and Hemp Seed Oil (Don Wirtshafter) 17. Economic and Environmental Potential of Cannabis (Robert C. Clarke and David W. Pate) APPENDICES A. Organizations for Therapeutic Cannabis B. Organizations Suppporting Access to Therapeutic Cannabis C. Resolution of the Virginia Nurses Association D. Excerpt from the National Nurses Society on Addictions' Position Paper "Access to Therapeutic Cannabis" E. Resolution of the American Public Health Association F. Editorial from The New England Journal of Medicine G. Organizations for the Overall Use of Cannabis or Hemp H. Sources of Cannabis/Hemp Products I. Additional Resources INDEX
Table of Contents ACKNOWLEDGMENTS INTRODUCTION (Mary Lynn Mathre) Part I. Legal Dilemmas of Cannabis Prohibition 1. People Behind the Pain (Norman Elliott Kent) 2. Legal Issues Related to the Medical Use of Marijuana (Kevin B. Zeese) Part II. Medicinal Characteristics of Cannabis 3. History of Therapeutic Cannabis (Michael Aldrich) 4. Pharmacology and Toxicity of Cannabis (Denis J. Petro) Part III. Indications for Therapeutic Use of Cannabis 5. As an Antiemetic and Appetite Stimulant for Cancer Patients (Daniel A. Dansak) 6. AIDS and the Wasting Syndrome (Walter Krampf) 7. Glaucoma: A Patient's View (Robert C. Randall) 8. The Use of Certain Cannabis Derivatives (Canasol) in Glaucoma (Manley West) 9. Spasticity and Chronic Pain (Denis Petro) 10. Seizure Disorders (Denis Petro) 11. Use of Cannabis or THC in Psychiatry (Milton Earl Burglass) 12. Cannabidiol as an Anxiolytic and Antipsychotic (Antonio W. Zuardi and Francisco S. Guimaraes) 13. Dosage and Administration of Cannabis (Madelyn Z. Brazis and Mary Lynn Mathre) Part IV. Special Considerations 14. Cannabis and Pregnancy (Melanie C. Dreher) 15. Risk of Dependence and Addiction (Mary Lynn Mathre) 16. Nutritional Value of Hemp Seed and Hemp Seed Oil (Don Wirtshafter) 17. Economic and Environmental Potential of Cannabis (Robert C. Clarke and David W. Pate) APPENDICES A. Organizations for Therapeutic Cannabis B. Organizations Suppporting Access to Therapeutic Cannabis C. Resolution of the Virginia Nurses Association D. Excerpt from the National Nurses Society on Addictions' Position Paper "Access to Therapeutic Cannabis" E. Resolution of the American Public Health Association F. Editorial from The New England Journal of Medicine G. Organizations for the Overall Use of Cannabis or Hemp H. Sources of Cannabis/Hemp Products I. Additional Resources INDEX
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497